Marine Microbes Research Update
Total Page:16
File Type:pdf, Size:1020Kb
MARINE MICROBES RESEARCH UPDATE JUNE Exploring Synergies between Three EU Flagship 2015 Marine Microrganism Research Projects PROJECT UPDATES P1 Micro B3, MaCuMBA & PharmaSea EVENTS P4 INTRODUCTION Ocean Sampling Day 2015, The ocean covers approximately ECMNP 2015 & Workshop for 70% of the Earth’s surface and up to Young Academics 80% of life on Earth is found in the ocean. Marine microorganisms are tiny, single-celled organisms that live in the ocean and account for more than 98% of ocean biomass. PROJECT COORDINATOR They offer an almost unlimited DISCUSSION P5 resource of enzymes and bioactive Marieke Reuver, Lucas Stal, compounds and could potentially provide clues that will help mitigate Marcel Jaspars & Frank Oliver climate change, control disease Glöckner and generate alternative energy sources. This newsletter provides updates and insights from three EU-funded MARINE MICR’OMICS FOR research projects that aim to BIOTECH APPLICATIONS improve our ability to exploit this virtually untapped resource of WORKSHOP P9 biotechnological potential. Industry Expert Workshop www.macumbaproject.eu www.microb3.eu www.pharma-sea.eu 1 PROJECT NEWS PROJECT NEWS PROJECT UPDATE MICRO B3: MARINE MICROBIAL BIODIVERSITY, BIOINFORMATICS AND BIOTECHNOLOGY PROGRAMME: FP7 Cooperation, Ocean of Tomorrow FP7-OCEAN-2011 TOTAL BUDGET: €11,507,843 EC CONTRIBUTION: €8,987,491 DURATION: January 2012 – December 2015 (48 months) COORDINATOR: Frank Oliver Glöckner; Jacobs University Bremen gGmbH, Germany CONSORTIUM: 32 partners from Germany, Belgium, France, Greece, Iceland, Ireland, Italy, Macedonia, Spain, The Netherlands, Turkey, United Kingdom, three international organisations ICES (Denmark), CIESM (Monaco), IUCN (Switzerland); including one large private company and six SMEs. WEB: www.microb3.eu Micro B3 SOCIAL MEDIA: www.facebook.com/microb3osd Micro B3 is improving Europe’s capacity for bioinformatics Bioinformatics work has led to interoperable structures and marine microbial data integration for the benefit for submission, storage and exchange of data between of a variety of disciplines in biosciences, technology, the established archives SeaDataNet, EurOBIS, the computing and law. It facilitates the whole process from European Nucleotide Archive (ENA at EBI) and the Micro sampling and data acquisition to analysis, leading to B3-IS. Several integrated software tools based on joint better understanding of marine ecosystems and their standards and interoperability structures can now be (meta)genomic background, thus paving the way for novel used in research, such as a Genes Mapserver (http:// biotechnological applications. blast2.mpi-bremen.de/gms), and a Metagenomic Trait Database (https://mb3is.megx.net/mg-traits). Micro B3 is developing and validating open access to biodiversity, genomic, oceanographic and Earth To support biotechnological applications, specific observation databases through the integrated Micro B3 bioinformatics tools have been developed for: Information System (Micro B3-IS). This system is building Computational prediction of substrate selectivity of on global standards for sampling and data processing homologues of genes with known activities with interoperability as a key feature for data transfer Determining functions of still unknown genes found of sequence and contextual data to and from users, in marine microbes using co-occurrence networks for institutions, and public repositories. determining hypothetical functions of unknown genes from marine microbes The Micro B3 partnership’s combined expertise facilitates Three-dimensional protein structure prediction the whole process of knowledge generation from the legal and technical aspects of sampling and data acquisition to Results from (meta)genome mining for anti-tumour integrated data analysis and sound statistics. compounds, enzyme databases, libraries, assays and new expression systems for experimental screening Research in Micro B3 has provided several annotation are becoming available. A range of promising microbial pipelines to identify sequences in metagenomic reads as cultures are being subjected to high-throughput well as the Multivariate AnalysiS Applications for Microbial processing. Industry leaders are targeted through expert Ecology (MASAME) tool, an interactive tool for ecological workshops and think tanks to promote understanding of analysis. Different biodiversity case studies have been the value of integrating environmental and ‘Omics’ data. chosen to explore the marine microbial ecosystem, including spatial monitoring done through expeditions Media contact: Johanna Wesnigk, Environmental and temporal monitoring programmes for long-term & Marine Project Management Agency, ecological research sites. [email protected] 1 2 PROJECT NEWS PROJECT NEWS PROJECT UPDATE MACUMBA: MARINE MICROORGANIMS:CULTIVATION METHODS FOR IMPROVING THEIR BIOTECHNOLOGICAL APPLICATIONS PROGRAMME: FP7 Cooperation, KBBE INSTRUMENT: Collaborative project TOTAL BUDGET: €12,015,209.80 EC CONTRIBUTION: €8,999,948.00 DURATION: August 2012 – July 2016 (48 months) CONSORTIUM: 23 partners from Austria, Belgium, Denmark, France, Germany, Iceland, Ireland, Italy, The Netherlands, Spain, and the UK COORDINATOR: Lucas Stal, Koninklijk Nederlands Instituut voor Onderzoek der Zee (NIOZ), The Netherlands MaCuMBA WEB: www.macumbaproject.eu SOCIAL MEDIA: www.facebook.com/MaCuMBAProject MaCuMBA focuses on the development of techniques that will increase the rate with which we can isolate Media contact: Marieke Reuver, AquaTT, marine microorganisms (of any of the three domains of [email protected] life: Bacteria, Archaea, Eukarya) and increase the success rate with which we can grow these organisms in the laboratory. It is expected that the marine environment harbours an untold diversity of these microorganisms. This unknown majority may possess novel and unexpected properties and bioactive compounds that could be used e.g. as pharmaceuticals. MaCuMBA therefore samples symbiotic microorganisms and microorganisms from a wide range of marine habitats including those from extreme environments; from which we expect particular interesting applications. MaCuMBA also screens newly isolated microorganisms for bioactive compounds. MaCuMBA has developed a selection of high throughput isolation techniques, including further development of colony picking robotics, the micro Petri dish, and gel encapsulating and cell sorting, in addition to single cell isolation techniques. MaCuMBA has sampled (and continues to sample) a wide variety of environments and has isolated many thousands of new strains. These are now being identified, stored in dedicated culture collections, and screened for bioactive compounds. MaCuMBA will end in 2016 with a large event that comprises an industry seminar and exhibition of the project’s achievements, back-to-back with an open science meeting on marine microbiology in the last week of June 2016 in Berlin-Adlershof. During that meeting a book on marine microbiology written by MaCuMBA’s scientists will be presented. 1 2 PROJECT NEWS PROJECT NEWS PROJECT UPDATE PHARMASEA: EXPLORING THE HIDDEN POTENTIAL: NOVEL BIOACTIVE COMPOUNDS PROGRAMME: FP7 Cooperation, KBBE TOTAL BUDGET: € 13,289,395 EC CONTRIBUTION: € 9,465,907 DURATION: October 2012 – September 2016 (48 months) COORDINATOR: Peter de Witte, Katholieke Universiteit Leuven, Belgium; scientific lead: Marcel Jaspars, Marine Biodiscovery Centre at the University of Aberdeen, United Kingdom CONSORTIUM: 24 partners from Belgium, UK, Austria, Denmark, Chile, China, Costa Rica, Germany, Ireland, Italy, New Zealand, Norway, South Africa, and Spain WEB: www.pharma-sea.eu PHARMASEA SOCIAL MEDIA: www.linkedin.com/company/pharmasea The PharmaSea project brings research groups together University of Tromsø in Norway and at the University around the world in search of novel antibiotics. The of Aberdeen in Scotland are showing initial signs of project focuses on the biodiscovery and the development antibacterial properties. The researchers have worked on and commercialisation of new substances from marine over 1,000 bacterial strains from many extreme locations organisms. on the globe including Greenland and Antarctica and have tested more than 12,000 extracts in more than 40,000 Its primary goal is to collect samples from the oceans, biological tests. A number of these have been highlighted home to some of the hottest, deepest and coldest as active in screens against infection and central nervous places on the planet. These samples will be screened to system diseases and a number of new compounds have uncover marine microbes and new bioactive compounds been identified. and to evaluate their potential as novel drug leads (e.g. antibiotics). A good start, with a long way still to go. The planned legacy of the PharmaSea project is to eradicate the issue of Access to really deep water is restricted by access to antibiotic resistance. Who knows where the next penicillin oceanography ships and deep-sea sampling equipment. will be found? Perhaps it will be in the icy Norwegian PharmaSea’s solution for this is to develop inexpensive Arctic or in a deep oceanic trench in the Pacific Ocean. and robust equipment based on that developed for the salvage industry. Using fishing vessels, researchers lower a sampler on a reel of cables to the trench bed to collect Media contact: Annette Doerfel, BIOCOM AG, sediment. [email protected] To find new species with capacity to produce new bioactive compounds, PharmaSea’s researchers will use selective isolation